Skip to main content

Hoffman Reid's Form 4 filing

Vor Biopharma Inc. (VOR) · filed Sep 18, 2025

Accession no.
0002050755-25-000008
Filed
Sep 18, 2025, 8:40 PM ET
Trade date
Sep 16, 2025
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 1 non-derivative transaction. Open-market sales total $688.9K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Hoffman ReidCIK 000151933910% Owner
Reprogrammed Interchange LLCCIK 000205075510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 16, 2025Common StockSSaleDisposed−447,278$1.54−$688,852.8532,781,209Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)